The customizable transcatheter aortic heart valve simulated use solutions from BDC Laboratories provide a complete, turnkey platform to evaluate transcatheter aortic valve replacement (TAVR/TAVI) implants and procedures for the treatment of aortic valve stenosis.
This aortic valve simulation solution consists of a left ventricle, functioning silicone aortic valve, aortic arch, descending aorta and femoral arteries. The simulated use model has access ports with integrated hemostatic valves at the femoral arteries and transapically to facilitate advancement and delivery of TAVR implants. Additional, custom access approaches through direct aortic or femoral vein can also be integrated into the simulated use system.